Joanne H Hasskamp
Overview
Explore the profile of Joanne H Hasskamp including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
138
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Palmer O, Hasskamp J, La H, Patwardhan P, Ghumman S, Baloda V, et al.
Lab Med
. 2022 Sep;
54(2):e54-e57.
PMID: 36065160
Objective: Independent assessment of SARS-CoV-2 antigen (COV2Ag) tests remains important as varying performance between assays is common. We assessed the performance of a new high-throughput COV2Ag test compared to SARS-CoV-2...
2.
Rapsinski G, Freeman M, Haidar G, Belle S, Hasskamp J, Wheeler S
J Clin Virol Plus
. 2022 Mar;
1(3):100026.
PMID: 35262012
Background: Children infected with SARS-CoV-2 are often asymptomatic or have only mild symptoms, leading to underestimation of disease prevalence in symptom-based testing strategies. Objectives: This study sought to determine pediatric...
3.
Wheeler S, Hasskamp J, Peck Palmer O
J Appl Lab Med
. 2020 Nov;
6(1):274-284.
PMID: 33221844
Background: A health disparity is a health outcome that presents in a lesser or greater extent between populations. Health disparities in diseases are products of complex interactions between social, economic,...
4.
Elias E, Hasskamp J, Sharma B
Cancers (Basel)
. 2013 Nov;
2(2):794-808.
PMID: 24281094
Cytokines and growth factors have biologic effects that could stimulate tumor growth, invasion and angiogenesis. The incidence of 24 factors was investigated in 25 cultured human melanoma cell lines and...
5.
Elias E, Hasskamp J, Sharma B
Cancers (Basel)
. 2013 Nov;
2(1):165-89.
PMID: 24281039
A review of the natural behavior of cutaneous melanoma, clinical and pathological factors, prognostic indicators, some basic research and the present and possible futuristic strategies in the management of this...
6.
Cronin J, Watkins-Chow D, Incao A, Hasskamp J, Schonewolf N, Aoude L, et al.
Cancer Res
. 2013 Aug;
73(18):5709-18.
PMID: 23913827
The transcription factor SOX10 is essential for survival and proper differentiation of neural crest cell lineages, where it plays an important role in the generation and maintenance of melanocytes. SOX10...
7.
OConnell M, Fiori J, Baugher K, Indig F, French A, Camilli T, et al.
J Invest Dermatol
. 2009 Jan;
129(7):1782-9.
PMID: 19177143
We have previously shown that Wnt5A and ROR2, an orphan tyrosine kinase receptor, interact to mediate melanoma cell motility. In other cell types, this can occur through the interaction of...
8.
Elias E, Zapas J, McCarron E, Beam S, Hasskamp J, Culpepper W
Cancer Biother Radiopharm
. 2008 Jul;
23(3):285-91.
PMID: 18593361
Granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-2 (IL-2) are 2 cytokines with distinct mechanisms of action that complement one another in the adjuvant management of melanoma. Forty-five patients with high-risk melanoma...
9.
Hasskamp J, Elias E, Zapas J
J Clin Immunol
. 2006 Jun;
26(4):331-8.
PMID: 16783532
Dendritic cells were assayed repeatedly in the peripheral blood of consenting melanoma patients receiving adjuvant biotherapy for high risk (stages IIb-IV) melanoma. Postoperatively, adjuvant biotherapy consisted of granulocyte-macrophage colony-stimulating factor...